Literature DB >> 9457657

Abnormal regional blood flow responses during and after exercise in human sympathetic denervation.

S Puvi-Rajasingham1, G D Smith, A Akinola, C J Mathias.   

Abstract

1. Blood pressure, superior mesenteric artery (SMA) and skeletal muscle blood flow, cardiac index (CI) and systemic vascular resistance responses to supine leg exercise were measured in six age-matched normal subjects (controls) and in eleven subjects with sympathetic denervation due to primary autonomic failure (AF). 2. During exercise, blood pressure rose in controls but fell markedly in AF. After exercise, blood pressure rapidly returned to baseline in controls but remained low in AF. During exercise, systemic vascular resistance fell in controls and AF but tended to fall further in AF and remained low post exercise. CI increased similarly in controls and AF. 3. During exercise, SMA blood flow fell similarly in controls and AF, but the fall initially was slower in AF; recovery was more rapid post exercise in controls. SMA vascular resistance tended to rise less and more slowly in AF and remained elevated post exercise. 4. Forearm muscle (FM) blood flow and FM vascular resistance did not change from resting values in controls or AF post exercise. After exercise, leg muscle (LM) blood flow rose and LM vascular resistance fell equally in both groups although LM blood flow remained elevated, 10 min post exercise in AF. 5. In sympathetically denervated humans, increased blood flow (due to excessive vasodilatation, lack of sympathetic restraint, or both) in leg muscle during and after exercise in combination with impaired splanchnic vasoconstriction in the early stages of exercise may have contributed to exercise-induced hypotension.

Entities:  

Mesh:

Year:  1997        PMID: 9457657      PMCID: PMC1160057          DOI: 10.1111/j.1469-7793.1997.841ba.x

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  21 in total

1.  Blood pressure during supine exercise in idiopathic orthostatic hypotension.

Authors:  R J MARSHALL; A SCHIRGER; J T SHEPHERD
Journal:  Circulation       Date:  1961-07       Impact factor: 29.690

2.  Changes in arterial-hepatic venous oxygen content difference during and after supine leg exercise.

Authors:  J M BISHOP; K W DONALD; S H TAYLOR; P N WORMALD
Journal:  J Physiol       Date:  1957-07-11       Impact factor: 5.182

Review 3.  Human cardiovascular adjustments to exercise and thermal stress.

Authors:  L B Rowell
Journal:  Physiol Rev       Date:  1974-01       Impact factor: 37.312

4.  Partition of blood flow to the cutaneous and muscular beds of the forearm at rest and during leg exercise in normal subjects and in patients with heart failure.

Authors:  R Zelis; D T Mason; E Braunwald
Journal:  Circ Res       Date:  1969-06       Impact factor: 17.367

Review 5.  Intestinal blood flow.

Authors:  D N Granger; P D Richardson; P R Kvietys; N A Mortillaro
Journal:  Gastroenterology       Date:  1980-04       Impact factor: 22.682

6.  The influence of thermoregulatory mechanisms on post-exercise hypotension in humans.

Authors:  P J Franklin; D J Green; N T Cable
Journal:  J Physiol       Date:  1993-10       Impact factor: 5.182

7.  Hemodynamics in Shy-Drager syndrome and treatment with indomethacin.

Authors:  Y Tsuda; K Kimura; S Yoneda; T Asai; N Handa; J Tanouchi; M Inoue; H Abe
Journal:  Eur Neurol       Date:  1983       Impact factor: 1.710

8.  Circulatory adaptation to arm and leg exercise in supine and sitting position.

Authors:  S Bevegård; U Freyschuss; T Strandell
Journal:  J Appl Physiol       Date:  1966-01       Impact factor: 3.531

9.  Validation of a Doppler technique for beat-to-beat measurement of cardiac output.

Authors:  N Mehta; V I Iyawe; A R Cummin; S Bayley; K B Saunders; E D Bennett
Journal:  Clin Sci (Lond)       Date:  1985-10       Impact factor: 6.124

10.  The pressor actions of noradrenaline and angiotension II in chronic autonomic failure treated with indomethacin.

Authors:  I B Davies; R Bannister; C Hensby; P S Sever
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335

View more
  9 in total

Review 1.  The cardiovascular challenge of exercising in the heat.

Authors:  José González-Alonso; Craig G Crandall; John M Johnson
Journal:  J Physiol       Date:  2007-09-13       Impact factor: 5.182

2.  Coupling of sympathetic and somatic motor outflows from the spinal cord in a perfused preparation of adult mouse in vitro.

Authors:  B A Chizh; P M Headley; J F Paton
Journal:  J Physiol       Date:  1998-05-01       Impact factor: 5.182

3.  Sympathetic nerves continue to regulate blood flow in exercising muscles.

Authors:  M J Joyner; W Wieling
Journal:  J Physiol       Date:  1997-12-15       Impact factor: 5.182

Review 4.  Pathophysiological basis of orthostatic hypotension in autonomic failure.

Authors:  A A Smit; J R Halliwill; P A Low; W Wieling
Journal:  J Physiol       Date:  1999-08-15       Impact factor: 5.182

Review 5.  Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies.

Authors:  Jose-Alberto Palma; Horacio Kaufmann
Journal:  Mov Disord       Date:  2018-03       Impact factor: 10.338

Review 6.  Orthostatic Hypotension in Parkinson Disease.

Authors:  Jose-Alberto Palma; Horacio Kaufmann
Journal:  Clin Geriatr Med       Date:  2019-09-06       Impact factor: 3.076

Review 7.  Exercise related syncope, when it's not the heart.

Authors:  C T Paul Krediet; Arthur A M Wilde; Wouter Wieling; John R Halliwill
Journal:  Clin Auton Res       Date:  2004-10       Impact factor: 4.435

Review 8.  Systematic review: the impact of exercise on mesenteric blood flow and its implication for preoperative rehabilitation.

Authors:  K A Knight; S J Moug; M A West
Journal:  Tech Coloproctol       Date:  2017-02-27       Impact factor: 3.781

9.  Orthostatic hypotension in hereditary transthyretin amyloidosis: epidemiology, diagnosis and management.

Authors:  Jose-Alberto Palma; Alejandra Gonzalez-Duarte; Horacio Kaufmann
Journal:  Clin Auton Res       Date:  2019-08-26       Impact factor: 4.435

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.